Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction

Author:

Ehrmann Dominic12ORCID,Laviola Luigi3,Priesterroth Lilli-Sophie14,Hermanns Norbert12ORCID,Babion Nils5,Glatzer Timor5ORCID

Affiliation:

1. Research Institute Diabetes Academy Mergentheim (FIDAM), Bad Mergentheim, Germany

2. Department of Clinical Psychology and Psychotherapy, University of Bamberg, Bamberg, Germany

3. Policlinico University of Bari “Aldo Moro,” Bari, Italy

4. Health Psychology, Institute of Psychology, Johannes Gutenberg-University Mainz, Mainz, Germany

5. Roche Diabetes Care GmbH, Mannheim, Germany

Abstract

Background: Extended glucose predictions are novel in diabetes management. Currently, there is no solution widely available. People with diabetes mellitus (DM) are offered features like trend arrows and limited predictions linked to predefined situations. Thus, the impact of extended glucose predictions on the burden of diabetes and person-reported outcomes (PROs) is unclear. Methods: In this online survey, 206 people with type 1 and type 2 diabetes (T1D and T2D), 70.9% and 29.1%, respectively, who participated in the dia·link online panel and were current continuous glucose monitoring (CGM) users, were presented with different scenarios of hypothetical extended glucose predictions. They were asked to imagine how low glucose predictions of 30 minutes and overnight as well as glucose predictions up to 2 hours would influence their diabetes management. Subsequently, they completed the Hypoglycemia Fear Survey II (HFS-II) and the T1 Diabetes Distress Scale (T1-DDS) by rating each item on a 5-point scale (−2: strong deterioration to +2: strong improvement) according to the potential change due to using glucose predictions. Results: For all glucose prediction periods, 30 minutes, up to 2 hours, and at nighttime, the surveyed participants expected moderate improvements in both fear of hypoglycemia (HFS-II: 0.57 ± 0.49) and overall diabetes distress (T1-DDS = 0.44 ± 0.49). The T1-DDS did not differ for type of therapy or diabetes. Conclusions: People with T1D and T2D would see glucose predictions as a potential improvement regarding reduced fear of hypoglycemia and diabetes distress. Therefore, glucose predictions represent a value for them in lowering the burden of diabetes and its management.

Funder

Roche Diabetes Care GmbH

Publisher

SAGE Publications

Reference36 articles.

1. Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden

2. Food and Drug Administration. Diabetes mellitus: efficacy endpoints for clinical trials investigating antidiabetic drugs and biological products guidance for industry. Draft guidance. 2023. https://www.fda.gov/media/168475/download. Accessed February 12, 2024.

3. World Health Organization (WHO). Basic documents (including amendments adopted up to 31 May 2019). 2020. https://apps.who.int/gb/bd/pdf_files/BD_49th-en.pdf. Accessed February 12, 2024.

4. Person‐reported outcomes in diabetes care: What are they and why are they so important?

5. Integrating the Use of Patient-Reported Outcomes for Both Clinical Practice and Performance Measurement: Views of Experts from 3 Countries

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Concept and Implementation of a Novel Continuous Glucose Monitoring Solution With Glucose Predictions on Board;Journal of Diabetes Science and Technology;2024-08-19

2. Predicting Glucose Values: A New Era for Continuous Glucose Monitoring;Journal of Diabetes Science and Technology;2024-08-19

3. Enhancing the Capabilities of Continuous Glucose Monitoring With a Predictive App;Journal of Diabetes Science and Technology;2024-08-19

4. Clinical Usage and Potential Benefits of a Continuous Glucose Monitoring Predict App;Journal of Diabetes Science and Technology;2024-08-19

5. The Promise of Hypoglycemia Risk Prediction;Journal of Diabetes Science and Technology;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3